Photo of Larissa Nekhlyudov,  MD, MPH

Larissa Nekhlyudov, MD, MPH

Harvard Medical School

Harvard Medical School
Phone: (617) 509-9983
Fax: (617) 859-8112

Larissa Nekhlyudov, MD, MPH

Harvard Medical School


  • Associate Professor, Population Medicine, Harvard Medical School
  • Director, Community Practice Core, Dana-Farber Cancer Institute



  • Member, Center Scientific Council

Research Abstract

Breast cancer outcomes, decision making and communication, cancer survivorship


Powered by Harvard Catalyst
  • Collins LC, Achacoso N, Haque R, Nekhlyudov L, Quesenberry CP, Schnitt SJ, Habel LA, Fletcher SW. Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study. Ann Surg Oncol 2015. PubMed
  • Palmer SC, Stricker CT, Panzer SL, Arvey SA, Baker KS, Casillas J, Ganz PA, McCabe MS, Nekhlyudov L, Overholser L, Partridge AH, Risendal B, Rosenstein DL, Syrjala KL, Jacobs LA. Outcomes and satisfaction after delivery of a breast cancer survivorship care plan: results of a multicenter trial. J Oncol Pract 2015; 11:e222-9. PubMed
  • Reed SC, Partridge AH, Nekhlyudov L. Shared Medical Appointments in Cancer Survivorship Care: A Review of the Literature. J Oncol Pract 2014. PubMed
  • Greenberg CC, Habel LA, Hughes ME, Nekhlyudov L, Achacoso N, Acton L, Schrag D, Jiang W, Edge S, Weeks JC, Punglia RS. Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ. Ann Surg Oncol 2014. PubMed
  • Rabin BA, Ellis JL, Steiner JF, Nekhlyudov L, Feuer EJ, Hankey BF, Cynkin L, Bayliss E. Health-care utilization by prognosis profile in a managed care setting: using the Surveillance, Epidemiology and End Results Cancer Survival Calculator SEER*CSC. J Natl Cancer Inst Monogr 2014; 2014:275-81. PubMed
  • Feuer EJ, Rabin BA, Zou Z, Wang Z, Xiong X, Ellis JL, Steiner JF, Cynkin L, Nekhlyudov L, Bayliss E, Hankey BF. The Surveillance, Epidemiology, and End Results Cancer Survival Calculator SEER*CSC: validation in a managed care setting. J Natl Cancer Inst Monogr 2014; 2014:265-74. PubMed
  • Mayer DK, Nekhlyudov L, Snyder CF, Merrill JK, Wollins DS, Shulman LN. American Society of Clinical Oncology clinical expert statement on cancer survivorship care planning. J Oncol Pract 2014. PubMed
  • Nekhlyudov L, Wenger N. Institute of medicine recommendations for improving the quality of cancer care: what do they mean for the general internist? J Gen Intern Med 2014; 29:1404-9. PubMed
  • Nekhlyudov L, Levit L, Hurria A, Ganz PA. Patient-centered, evidence-based, and cost-conscious cancer care across the continuum: Translating the Institute of Medicine report into clinical practice. CA Cancer J Clin 2014. PubMed
  • Boyajian RN, Grose A, Grenon N, Roper K, Sommer K, Walsh M, Snavely A, Neary S, Partridge A, Nekhlyudov L. Desired elements and timing of cancer survivorship care: one approach may not fit all. J Oncol Pract 2014; 10:e293-8. PubMed
  • Nekhlyudov L. Integrating primary care in cancer survivorship programs: models of care for a growing patient population. Oncologist 2014; 19:579-82. PubMed
  • Blanch-Hartigan D, Forsythe LP, Alfano CM, Smith T, Nekhlyudov L, Ganz PA, Rowland JH. Provision and discussion of survivorship care plans among cancer survivors: results of a nationally representative survey of oncologists and primary care physicians. J Clin Oncol 2014. PubMed
  • Nekhlyudov L, Aziz NM, Lerro C, Virgo KS. Oncologists' and primary care physicians' awareness of late and long-term effects of chemotherapy: implications for care of the growing population of survivors. J Oncol Pract 2014; 10:e29-36. PubMed
  • Stout NK, Nekhlyudov L, Li L, Malin ES, Ross-Degnan D, Buist DS, Rosenberg MA, Alfisher M, Fletcher SW. Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011. JAMA Intern Med 2014; 174:114-21. PubMed
  • Bowles EJ, Wernli KJ, Gray HJ, Bogart A, Delate T, O'Keeffe-Rosetti M, Nekhlyudov L, Loggers ET. Diffusion of Intraperitoneal Chemotherapy in Women with Advanced Ovarian Cancer in Community Settings 2003-2008: The Effect of the NCI Clinical Recommendation. 2014; 4:43. PubMed
  • Rabin BA, Gaglio B, Sanders T, Nekhlyudov L, Dearing JW, Bull S, Glasgow RE, Marcus A. Predicting cancer prognosis using interactive online tools: a systematic review and implications for cancer care providers. Cancer Epidemiol Biomarkers Prev 2013; 22:1645-56. PubMed
  • Mazor KM, Gaglio B, Nekhlyudov L, Alexander GL, Stark A, Hornbrook MC, Walsh K, Boggs J, Lemay CA, Firneno C, Biggins C, Blosky MA, Arora NK. Assessing patient-centered communication in cancer care: stakeholder perspectives. J Oncol Pract 2013; 9:e186-93. PubMed
  • Collins LC, Achacoso N, Haque R, Nekhlyudov L, Fletcher SW, Quesenberry CP, Schnitt SJ, Habel LA. Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ. Breast Cancer Res Treat 2013. PubMed
  • Geiger AM, Castellino SM, Tooze JA, Altschuler A, Month S, Mertens AC, Nekhlyudov L, Greene SM. Potential Role of Community-Based Healthcare System Data in Research on Survivors of Adolescent and Young Adult Cancer. J Adolesc Young Adult Oncol 2013; 2:53-58. PubMed
  • Nekhlyudov L, Greene SM, Chubak J, Rabin B, Tuzzio L, Rolnick S, Field TS. Cancer research network: using integrated healthcare delivery systems as platforms for cancer survivorship research. J Cancer Surviv 2013; 7:55-62. PubMed
  • Goddard KA, Bowles EJ, Feigelson HS, Habel LA, Alford SH, McCarty CA, Nekhlyudov L, Onitilo AA, Rahm AK, Webster JA. Utilization of HER2 genetic testing in a multi-institutional observational study. Am J Manag Care 2012; 18:704-12. PubMed
  • Bowles EJ, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, Allen LA, Nekhlyudov L, Goddard KA, Davis RL, Habel LA, Yood MU, McCarty C, Magid DJ, Wagner EH, . Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. Journal of the National Cancer Institute 2012; 104:1293-305. PubMed
  • Chubak J, Tuzzio L, Hsu C, Alfano CM, Rabin BA, Hornbrook MC, Spegman A, Von Worley A, Williams A, Nekhlyudov L. Providing care for cancer survivors in integrated health care delivery systems: practices, challenges, and research opportunities. J Oncol Pract 2012; 8:184-9. PubMed
  • Stout NK, Nekhlyudov L. Early uptake of breast magnetic resonance imaging in a community-based medical practice, 2000-2004. J Womens Health (Larchmt) 2011. PubMed
  • Haque R, Achacoso NS, Fletcher SW, Nekhlyudov L, Collins LC, Schnitt SJ, Quesenberry CP, Habel LA. Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans. Am J Manag Care 2010; 16:351-60. PubMed
  • Yeh JM, Nekhlyudov L, Goldie SJ, Mertens AC, Diller L. A model-based estimate of cumulative excess mortality in survivors of childhood cancer. Ann Intern Med 2010; 152:409-17, W131-8. PubMed
  • Boyajian R, Nekhlyudov L. The quest to solve the cancer survivorship puzzle: starting at the edges. Int J Psychiatry Med 2010; 40:183-6. PubMed
  • Nekhlyudov L, Latosinsky S. The interface of primary and oncology specialty care: from symptoms to diagnosis. J Natl Cancer Inst Monogr 2010; 2010:11-7. PubMed
  • Collins LC, Achacoso N, Nekhlyudov L, Fletcher SW, Haque R, Quesenberry CP, Puligandla B, Alshak NS, Goldstein LC, Gown AM, Schnitt SJ, Habel LA. Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients. Am J Surg Pathol 2009; 33:1802-8. PubMed
  • Hong S, Nekhlyudov L, Didwania A, Olopade O, Ganschow P. Cancer survivorship care: exploring the role of the general internist. J Gen Intern Med 2009; 24 Suppl 2:S495-500. PubMed
  • Nekhlyudov L, Greenfield S. Cancer survivorship care for the general internist: have we paved the way for a smoother transition? J Gen Intern Med 2009; 24 Suppl 2:S381-2. PubMed
  • Aiello Bowles EJ, Tuzzio L, Ritzwoller DP, Williams AE, Ross T, Wagner EH, Neslund-Dudas C, Altschuler A, Quinn V, Hornbrook M, Nekhlyudov L. Accuracy and complexities of using automated clinical data for capturing chemotherapy administrations: implications for future research. Med Care 2009; 47:1091-7. PubMed
  • Nekhlyudov L, Braddock CH. An approach to enhance communication about screening mammography in primary care. J Womens Health (Larchmt) 2009; 18:1403-12. PubMed
  • Nekhlyudov L,Habel LA,Achacoso NS,Jung I,Haque R,Collins LC,Schnitt SJ,Quesenberry CP Jr,Fletcher SW. Adherence to Long-Term Surveillance Mammography Among Women With Ductal Carcinoma In Situ Treated With Breast-Conserving Surgery. J Clin Oncol 2009; 27:3211-6. PubMed
  • Nekhlyudov L, Bush T, Bonomi AE, Ludman EJ, Newton KM. Physicians' and women's views on hormone therapy and breast cancer risk after the WHI: a qualitative study. Women Health 2009; 49:280-93. PubMed
  • Weingart SN,Saadeh MG,Simchowitz B,Gandhi TK,Nekhlyudov L,Studdert DM,Puopolo AL,Shulman LN. Process of care failures in breast cancer diagnosis. J Gen Intern Med 2009; 24:702-9. PubMed
  • Nekhlyudov L. "Doc, should I see you or my oncologist?": a primary care perspective on opportunities and challenges in providing comprehensive care for cancer survivors. J Clin Oncol 2009; 27:2424-6. PubMed
  • Nekhlyudov L,Kiarsis K,Elmore JG. MRI of the breast: does the internet accurately report its beneficial uses and limitations? Breast J 2009; 15:189-93. PubMed
  • Habel LA, Achacoso NS, Haque R, Nekhlyudov L, Fletcher SW, Schnitt SJ, Collins LC, Geiger AM, Puligandla B, Acton L, Quesenberry CP. Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting. Breast Cancer Res 2010; 11:R85. PubMed
  • Nekhlyudov L,Li R,Fletcher SW. Informed decision making before initiating screening mammography: does it occur and does it make a difference? Health Expect 2008; 11:366-75. PubMed
  • Nekhlyudov L,Nicola M,Jung I,Buechler E. Clinicians' documentation of breast findings: lessons learned from a figure of a hypothetical breast lesion. Breast J 2008; 14:399-401. PubMed
  • Altschuler A, Nekhlyudov L, Rolnick SJ, Greene SM, Elmore JG, West CN, Herrinton LJ, Harris EL, Fletcher SW, Emmons KM, Geiger AM. Positive, negative, and disparate--women's differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J 2008; 14:25-32. PubMed
  • Nekhlyudov L, Nicola M, Jung I, Buechler E. Clinicians' knowledge and attitudes about breast symptom management: is there a use for clinical guidelines? J Womens Health (Larchmt) 2008; 17:57-65. PubMed
  • Collins LC, Achacoso NA, Nekhlyudov L, Fletcher SW, Haque R, Quesenberry CP Jr, Alshak NS, Puligandla B, Brodsky GL, Schnitt SJ, Habel LA. Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients. Mod Pathol 2007; 20:1149-55. PubMed
  • Rolnick SJ, Altschuler A, Nekhlyudov L, Elmore JG, Greene SM, Harris EL, Herrinton LJ, Barton MB, Geiger AM, Fletcher SW. What women wish they knew before prophylactic mastectomy. Cancer Nurs 2007; 30:285-91; quiz 292-3. PubMed
  • Geiger AM, Nekhlyudov L, Herrinton LJ, Rolnick SJ, Greene SM, West CN, Harris EL, Elmore JG, Altschuler A, Liu IL, Fletcher SW, Emmons KM. Quality of Life After Bilateral Prophylactic Mastectomy. Ann Surg Oncol 2007; 14:686-94. PubMed
  • Nekhlyudov L, Kroenke CH, Jung I, Holmes MD, Colditz GA. Prospective changes in quality of life after ductal carcinoma-in-situ: results from the Nurses' Health Study. J Clin Oncol 2006; 24:2822-7. PubMed
  • Geiger AM, West CN, Nekhlyudov L, Herrinton LJ, Liu IL, Altschuler A, Rolnick SJ, Harris EL, Greene SM, Elmore JG, Emmons KM, Fletcher SW. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. J Clin Oncol 2006; 24:1350-6. PubMed
  • Spangler L, Reed SD, Nekhyludov L, Grothaus LC, LaCroix AZ, Newton KM. Provider attributes associated with hormone therapy prescribing frequency. Menopause 2009; 16:810-16. PubMed